Related Experiment Video
Updated: Jul 17, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Poor prognosis of heart transplant patients with end-stage renal failure
Emmanuel Villar1, Pascale Boissonnat, Laurent Sebbag
1Department of Nephrology, Dialysis and Transplantation, Hospices Civils de Lyon, Lyon Sud Hospital, Claude Bernard University, France. emmanuel.villar@chu-lyon.fr
Insights
Heart transplant (HT) patients with chronic kidney disease (CKD) requiring dialysis for end-stage renal failure (ESRF) have significantly poorer survival rates compared to non-HT patients. Renal transplant is recommended as the preferred ESRF treatment for HT recipients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Chronic kidney disease (CKD) and end-stage renal failure (ESRF) are significant complications following heart transplantation (HT).
- Comparing survival outcomes for heart transplant (HT) recipients versus non-HT patients initiating dialysis is crucial for understanding post-transplant complications.
Purpose of the Study:
- To compare the survival rates of heart transplant (HT) patients with end-stage renal failure (ESRF) undergoing dialysis against non-HT patients on dialysis.
- To identify causes of ESRF and mortality in HT patients post-dialysis initiation.
Main Methods:
- A cohort of 539 newly dialyzed patients between 1995 and 2005 were prospectively followed.
- Multivariate survival analysis using the Cox model was performed, adjusting for baseline characteristics.
Main Results:
- Heart transplant (HT) patients were younger at dialysis initiation (58.6 vs. 63.0 years).
- Calcineurin inhibitor nephrotoxicity was the primary cause of ESRF in 47.6% of HT patients.
- Adjusted hazard ratio for death in HT vs. non-HT patients was 2.27 (P=0.003), with sudden death being more common in HT patients (33.3% vs. 10.4%).
- Five HT patients received renal transplants and survived; only one of 16 remaining HT patients on dialysis survived.
Conclusions:
- Heart transplant (HT) patients reaching end-stage renal failure (ESRF) exhibit poor survival on dialysis compared to non-HT patients.
- Improved renal function management and evaluation of non-nephrotoxic immunosuppressants are necessary for CKD patients post-HT.
- Renal transplantation should be considered the optimal ESRF treatment for HT recipients.
Background:
Chronic kidney disease (CKD) and end-stage renal failure (ESRF) are major complications after a heart transplant. The aim of this study is to compare survival in heart transplant (HT) vs non-heart transplant (non-HT) patients starting dialysis.
Methods:
Survival was studied among the 539 newly dialysed patients between 1 January 1995 and 31 December 2005 in our Department. All patients were prospectively followed from the date of first dialysis up to death or 31 December 2005. Multivariate survival analysis adjusted on baseline characteristics was performed with the Cox model.
Results:
There were 21 HT patients and they were younger than non-HT patients at first dialysis: 58.6+/-11.6 vs 63.0+/-16.2 years (P=0.09). Calcineurin inhibitor nephrotoxicity was the main cause of ESRF in HT patients (47.6%). Crude 1, 3 and 5-year survival rates in HT and in non-HT patients were as follows: 76.2%, 57.1%, 28.6% and 79.1%, 58.7%, 46.7% (P=0.2). The adjusted hazard ratio of death in HT vs non-HT patients was 2.27 [1.33-3.87], P=0.003. Sudden death was the main cause of death in HT patients, in 33.3% vs 10.4% in non-HT patients (P=0.01). Five HT patients benefited from renal transplant. They were all alive at the end of the study period, while one patient among the 16 remaining on dialysis survived.
Conclusion:
HT patients with CKD who reached ESRF have a poor outcome after starting dialysis in comparison with other ESRF patients. Improvement in renal function management in the case of CKD is needed in these patients and non-nephrotoxic immunosuppressive regimens have to be evaluated. Renal transplant should be the ESRF treatment of choice in HT patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management